Meet in Italy for Life Sciences Brokerage Event 2026

13 – 14 Oct 2026 | Roma, Italy

ServiceUpdated on 27 September 2026

Drug Repurposing & Epigenetic Screening Platform for Age-Related Degenerative Diseases

Managing director and CFO at Oliba Healthcare and Pharma

Roma, Italy

About

ADAPTherapeutics is a University of Padova spin-off developing disease-modifying therapies for age-related degenerative diseases, including neurodegenerative, cardiovascular and metabolic conditions. We act upstream of the disease. Instead of treating cellular damage, we identify drugs able to correct the pathological genomic remodeling that drives it.

Our proprietary platform defines disease-specific molecular signatures from human patient samples. It then screens already-commercialized compounds through Drug-seq transcriptomic profiling and computational analysis. Because we start from drugs with established safety profiles, we shorten timelines, reduce risk and accelerate regulatory pathways. Our pipeline includes vorinostat (SAHA), decitabine and JQ1, now in pre-clinical validation.

We offer pharma and biotech partners phenotypic and transcriptomic screening, indication expansion and repurposing studies, and co-development of new therapeutic assets. Our team combines expertise in epigenetics with international experience in regulatory affairs and market access. Contact us to explore a collaboration.

Type

  • Research & Development
  • Testing & Analysis

Organisation

Oliba Healthcare and Pharma

Consultant

Roma, Italy

Similar opportunities